MEDIROM (MRM) outlines new tech device and digital asset plans in 6-K

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

MEDIROM Healthcare Technologies Inc. submitted a Form 6-K reporting that it is issuing a press release about the expected introduction of a new technological device at certain relaxation salon locations and related plans regarding digital assets. The press release is furnished as Exhibit 99.1 and is provided for informational purposes under the Exchange Act, without being treated as filed for liability purposes or automatically incorporated into other securities law filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

Accepted by SEC EDGAR 08/22/2025 - 04:30 PM

FAQ

What did MEDIROM (MRM) report in this Form 6-K?

MEDIROM Healthcare Technologies Inc. reported that it is issuing a press release about the expected introduction of a new technological device at certain relaxation salon locations and related plans regarding digital assets, and furnished that press release as Exhibit 99.1.

What is the main business update mentioned for MEDIROM (MRM)?

The update concerns the Company’s expected introduction of a new technological device at certain relaxation salon locations along with related plans regarding digital assets, as described in a press release furnished with this report.

How is the MEDIROM (MRM) press release provided to investors?

The press release is furnished as Exhibit 99.1 to the Form 6-K, meaning it is attached to the report as an exhibit for investors to review.

Does this MEDIROM (MRM) Form 6-K count as a filed document under Section 18?

The Company states that the information in this Form 6-K, including the exhibit, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section.

Is the MEDIROM (MRM) press release automatically incorporated into other SEC filings?

The Company explains that the information in this Form 6-K and its exhibit is not deemed incorporated by reference into any Securities Act or Exchange Act filing, except to the extent specifically provided in such a filing.

Who signed this MEDIROM (MRM) Form 6-K?

The report was signed on behalf of MEDIROM Healthcare Technologies Inc. by Fumitoshi Fujiwara, the Company’s Chief Financial Officer.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August, 2025

Commission File Number 001-39809

MEDIROM HEALTHCARE TECHNOLOGIES INC.

(Translation of registrant’s name into English)

2-3-1 Daiba, Minato-ku

Tokyo 135-0091, Japan

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form 20-F ☐ Form 40-F

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Issuance of Press Release

On August 22, 2025, MEDIROM Healthcare Technologies Inc. (the “Company”) is issuing a press release relating to the expected introduction of a new technological device at certain relaxation salon locations and related plans regarding digital assets. A copy of the press release is furnished as Exhibit 99.1 hereto.

The information furnished in this report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.

EXHIBIT INDEX


Exhibit No.		Description
99.1		Press release of the Company

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MEDIROM HEALTHCARE TECHNOLOGIES INC.
Date: August 22, 2025
	By:	/s/ Fumitoshi Fujiwara
		Name:	Fumitoshi Fujiwara
		Title:	Chief Financial Officer

Source: View Original Filing on SEC EDGAR